Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
about
Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluidsProtection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteinsExpression and function of membrane attack complex inhibitory proteins on thyroid follicular cellsCD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cellsIsolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complementInhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolyticaInfectious diseases associated with complement deficiencies.Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.Surface functionalization of gold nanoparticles with red blood cell membranesHistorical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'.Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.Complement induces a transient increase in membrane permeability in unlysed erythrocytes.The complement system in human reproduction.Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytesKilling of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.Expression and localization of proteins of the complement system in human skin.Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinasePersistent complement activation on tumor cells in breast cancer.Regulation of complement membrane attack complex formation in myocardial infarction.Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells.Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity.Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis.Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus.Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.Killing machines: three pore-forming proteins of the immune system.Bacteria under stress by complement and coagulation.Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.Membrane-associated proteins regulating the complement system: functions and deficiencies.Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.
P2860
Q24528248-F0ABB260-6CB8-4CCD-8944-19A68D089D78Q24541458-93C655EE-8411-41EC-B4E8-EFCFE14343F4Q24541460-1038EC93-DF96-4C95-972F-023D740C65D6Q24681862-D2BC8E51-C1F4-43DF-BD87-F245C4818013Q28569128-00B0D74D-DBBC-4F17-9F84-DE3FB15D6B9AQ30311439-2128182F-08DD-47E0-9039-CC6B91C38A4DQ30450183-3E39C852-C89C-4304-93C6-407B938A7E75Q33585897-A237447D-59B0-4BF3-90F4-9471E1699D20Q34067202-6505D2C4-FA64-41BB-B9C4-B3B687B1D2B7Q34120817-42F89815-984E-4F5C-9518-809A7D3DCD21Q34304219-9194CA57-BDA2-4C67-A94B-BD155C1CF3B1Q34560032-06F3E2FB-7E76-4DD1-B7C1-F03167FA3323Q35343231-B3537717-1B70-4DAE-81B3-BA820B9934D9Q35575831-57899E52-B710-4C7A-82C6-B8D9891A8BDCQ35576037-7BA3B544-6254-463C-93F9-7914AB203CE4Q35609010-85A42957-9EF4-4E20-98B3-AB98464587DDQ35763321-5456248B-8DE1-4867-9216-1425F9EC2131Q35766363-AAC0A208-D611-40F0-BE10-AC7827FFAAA6Q35782339-418AD68C-2721-4FDC-9F87-36AD5715EFA6Q35811297-1E4BC2F2-4A9D-4B84-98C2-F785814F39B5Q35816948-080C84B3-EBDB-4816-9508-78D408261293Q35831680-5B205BFA-0880-43F6-A319-EA98079F2FA3Q35832905-77815CE3-F0A1-46F0-9604-9AF406C5BAEDQ36223156-F455593D-A1C2-4239-9B55-40412F3E5F8EQ36353284-35A59FC2-2D3A-4D06-935F-B19C5A95FCC6Q36354070-843EF7E8-A1E9-4366-BEFC-EC0349E48C15Q36355672-AAC8C8A6-E083-4FBE-A12C-331290A924ACQ36356128-E27974DE-AAC6-4788-97DD-69F53C5CC007Q36356447-F778C365-48BC-4D75-A00B-17E407298360Q36431698-9089714C-74EC-4E65-8988-C5A9AFDA4E6CQ36691261-D648F0BA-858B-4A7D-BB3F-53251AD5D784Q36803615-8F7DF833-3F59-485F-B5EE-853A0E563DCAQ37162038-1473B5B5-5E03-4450-ADBC-E2E4D5E950ACQ37480974-82D15AB2-C55A-4C53-B43F-CAE128ADF461Q37693343-523DEBBC-80F3-474B-A448-6FBCD1E1DCD5Q38234314-E8A6360F-D183-41A2-BF90-3CD0B510B535Q38712865-4C1E7F0D-C5D6-4DA3-8CEF-7B463A7D1481Q38747540-5405B8B6-4E0D-48B4-9C07-9D62AACE2F14Q40488634-E77E9F18-663D-431E-BFAD-2D0760AC7AE6Q41093280-5B98CAB5-F087-4950-A998-5B5B750F0929
P2860
Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isolation of a human erythrocy ...... lement transmembrane channels.
@en
Isolation of a human erythrocy ...... lement transmembrane channels.
@nl
type
label
Isolation of a human erythrocy ...... lement transmembrane channels.
@en
Isolation of a human erythrocy ...... lement transmembrane channels.
@nl
prefLabel
Isolation of a human erythrocy ...... lement transmembrane channels.
@en
Isolation of a human erythrocy ...... lement transmembrane channels.
@nl
P2093
P2860
P356
P1476
Isolation of a human erythrocy ...... lement transmembrane channels.
@en
P2093
H J Müller-Eberhard
L S Zalman
P2860
P304
P356
10.1073/PNAS.83.18.6975
P407
P577
1986-09-01T00:00:00Z